Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...

with submissions to the European Medicines Agency (EMA) and the UK’s Medicines and Healthcare products Regulatory Agency ...

Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ... Read ...

Global health is likely to be radically altered with Donald Trump in the White House. For starters, the president-elect has ...

While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...

While Várhelyi praised the European Medicines Agency (EMA) in his hearing last week, MEPs are still pointing to Budapest’s approach to the Covid-19 pandemic — when it was the only EU country to ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

This came after Takeda Biopharmaceuticals presented the proposal for an update in the package insert regarding home infusion ...

If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.

Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...

Memorandum of Understanding has been signed NEW YORK, Nov. 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...